(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202109 | 202009 | % Var | 202109 | 202009 | % Var | 202103 | 202003 | % Var | |
| Sales | 21.42 | 20.74 | 3.28 | 60.35 | 43.89 | 37.50 | 101.72 | 108.58 | -6.32 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.32 | 0.55 | -41.82 | 0.00 | 0.00 | 0.00 |
| PBIDT | -1.76 | 1.89 | -193.12 | 3.43 | 4.75 | -27.79 | 3.58 | 5.05 | -29.11 |
| Interest | 0.06 | 0.03 | 100.00 | 0.10 | 0.06 | 66.67 | 1.73 | 1.17 | 47.86 |
| PBDT | -1.82 | 1.86 | -197.85 | 3.33 | 4.69 | -29.00 | 1.85 | 3.88 | -52.32 |
| Depreciation | 0.20 | 0.20 | 0.00 | 0.40 | 0.40 | 0.00 | 0.81 | 0.79 | 2.53 |
| PBT | -2.02 | 1.66 | -221.69 | 2.93 | 4.29 | -31.70 | 1.04 | 3.09 | -66.34 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | -2.02 | 1.66 | -221.69 | 2.93 | 4.29 | -31.70 | 1.04 | 3.09 | -66.34 |
| Equity | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 | 44.81 | 44.81 | 0.00 |
| PBIDTM(%) | -8.22 | 9.11 | -190.17 | 5.68 | 10.82 | -47.48 | 3.52 | 4.65 | -24.33 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1673.50 |
| Dr. Reddys Lab | 1238.75 |
| Cipla | 1240.00 |
| Zydus Lifesciences | 942.95 |
| Lupin | 2336.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: